Cyclin-dependent kinase 4/6 inhibitor in combination with endocrine therapy versus endocrine therapy only for advanced breast cancer: a systematic review and meta-analysis

BACKGROUND: The resistance to endocrine therapy poses a significant challenge to the management of advanced breast cancer with hormone receptor (HR) positive and human epidermal growth factor receptor 2 (Her-2) negative. The purpose of this study was to further examine the efficacy and safety of cyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhi-Hong, Zhang, Heng, Wei, Deng-Hui, Xie, Li-Li, Xu, Chun-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798229/
https://www.ncbi.nlm.nih.gov/pubmed/35117411
http://dx.doi.org/10.21037/tcr.2019.11.46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798229/
https://www.ncbi.nlm.nih.gov/pubmed/35117411
http://dx.doi.org/10.21037/tcr.2019.11.46

Ejemplares similares